Type 2 diabetes in youth is especially unhealthy
(HealthDay)—The earlier in life type 2 diabetes arises, the deadlier it is, a new analysis finds.
Dec 15, 2020
0
8
(HealthDay)—The earlier in life type 2 diabetes arises, the deadlier it is, a new analysis finds.
Dec 15, 2020
0
8
Patients diagnosed with non-cardiac chest pain are reluctant to believe they do not have heart disease. A new study shows that explaining the test results convinces patients and reduces the likelihood of future chest pain. ...
Dec 12, 2020
0
6
Getting a high-dose flu shot instead of a regular dose doesn't further reduce the risk of serious flu-complications, hospitalization or death in people with heart disease, new research shows.
Dec 10, 2020
0
3
About five percent of patients experience heart muscle injury around the time of their surgery for a noncardiac condition, yet guideline recommendations to identify patients at risk using biomarkers are not being followed. ...
Dec 10, 2020
0
8
Healthcare professionals can estimate who is at most risk for dying from COVID-19, including seniors and those with a variety of health conditions. However, until recently, that estimate has mostly been based on judgment ...
Dec 7, 2020
0
3
For cardiovascular health to improve in the general population, healthcare systems will need to collect and assess treatment data, establish collaboration between researchers and healthcare professionals, and evolve patient ...
Dec 3, 2020
0
10
A 2-month-old infant diagnosed with COVID-19 experienced reversible myocardial injury and heart failure, similar to COVID-19 related heart issues seen in adults, according to a case published in JACC: Case Reports. The infant ...
Dec 2, 2020
0
5
(HealthDay)—Repeat this: The key to helping people with diabetes stay healthier and out of the hospital could be as simple as better communication.
Nov 30, 2020
0
3
(HealthDay)—Frequent, short exercise sessions may be better for diabetes patients' blood vessels than longer and fewer workouts, and that may reduce their risk of heart disease, according to a new study.
Nov 26, 2020
0
39
The primary results from the RIVER Trial, Rivaroxaban for Valvular Heart disease and Atrial Fibrillation, show that rivaroxaban is comparable to warfarin, which is currently the standard of care anticoagulant prescribed for ...
Nov 16, 2020
0
1